Background: The iDSI reference case, originally published in 2014, aims to improve the quality 30 and comparability of cost-effectiveness analyses (CEAs). This study assesses whether the 31 development of the guideline has improved the reporting and methodology for CEAs using 32 disability-adjusted life-years (DALYs). 33 Methods: We analyzed the Tufts Medical Center Global Health CEA Registry to identify cost-34 per-DALY averted studies published from 2011 to 2017. Among each of 11 principles in the 35
Decision problem (population, intervention, comparator, outcome), evaluation's limitations, and declarations of interest are fully described.
Comparator(s)
Intervention(s) currently offered to the population (standard of care) is the base case comparator.
Comparator and its availability is clearly stated, and outcomes reported in incremental cost effectiveness ratio.
Evidence
Systematic literature review is used as source of evidence.
Methods of evidence collection are stated and sources of parameters are cited. Measure of health outcome † DALYs are used as the base case outcome measure.
Methods for weighting of DALYs are stated.
Costs
Costs are relevant to the context and stated perspective, and include implementation costs.
Costs are reported in local currency and USD.
Time horizon and discount rate
Lifetime time horizon and 3% discount rate for costs and outcomes are used in base case.
Time horizon and discount rate are clearly stated.
Non-health effects and costs outside health budget (perspective)
Societal perspective is used in base case, and relevant costs to this perspective (including direct health costs) are included.
Perspective and base case outcomes are clearly stated.
Heterogeneity
Heterogeneity is analyzed for appropriate subgroups.
Subgroup characteristics and analysis of heterogeneity are clearly described.
Uncertainty
Sensitivity analyses are performed on parameter source uncertainty (deterministic), parameter precision (probabilistic), and analysis structure (structural). 
Magnitude of uncertainty in the

88
Global Health CEA Registry 89 We analyzed data from the Tufts Medical Center Global Health CEA Registry, a 90 continually updated database of English-language economic evaluations in the form of cost-per-91 DALYs averted (12). Among 620 cost-per-DALY averted studies in the database, we selected a 92 subset (N = 398) published three years before and after the initial release of the iDSI reference 93 case (2011) (2012) (2013) (2014) (2015) (2016) (2017) to examine the impact of its publication on the literature. We focused 94 particularly on economic evaluations using the DALY metric because it is recommended as a Adherence score 104 We first translated all 30 methodological specifications and 38 reporting standards 105 (across 11 principles) listed in the reference case into questions with discrete yes/no outcomes 106 (Appendix S1). We then designated reference case elements as "required" or "optional" based on 107 our interpretation of the language in the report. We deemed 19 methodological and 21 reporting 108 specifications "required".
111
Our base-case analysis examined adherence scores consisting only of "required" 112 elements. We evaluated each published cost-per-DALY averted study's adherence to reporting 113 standards (0-21 items) and methodological specifications (0-19 items). We then recorded for 114 each article an overall reporting adherence score (proportion of 21 reporting standards adhered 115 to) and an overall methodological adherence score (proportion of 19 methodological 116 specifications adhered to).
117
Analysis 118 Descriptive analysis 119 We examined the association between adherence score and certain study characteristics, 120 including whether the study cited the reference case, the study funder characteristics, and journal 121 attributes. We categorized study funders into the following groups (not mutually exclusive): 122 academic, government, healthcare organization, industry, intergovernmental organization, 123 BMGF, non-BMGF, and other. We also stratified selected articles into clinical versus non-124 clinical journals using SCImago Journal Rank's subject categorization (medicine vs. health 125 policy, public health, non-health) (15). Finally, we recorded 2016 journal impact factor quartiles 126 and categorized studies as high impact (first quartile), medium impact (second quartile), or low-127 impact (third and fourth quartiles) (15).
128
Statistical analysis 129
To examine whether the iDSI guideline has since its release in 2014 improved the was highest for the following principles: uncertainty (mean of 100%), comparator (97%), and 186 evidence (95%). Methodological specification adherence was highest for the outcome measure 187 (100%), transparency (89%), and evidence (74%) principles (Figure 2 ). Reporting standard adherence exceeded methodological specification adherence for the 193 following principles: comparator (97% vs. 36%), evidence (95% vs. 74%), time 194 horizon/discounting (82% vs. 57%), perspective (85% vs. 64%), and uncertainty (100% vs. 57%) 195 (Figure 3 ). Methodology adherence scores were higher than reporting adherence scores for the 196 following principles: transparency (86% vs. 89%), outcome (54% vs. 100%), and costs (54% vs. 197 65%). Articles seldom addressed the budget impact (9% reporting adherence, 10% methodology) 198 or equity (7% reporting adherence, 7% methodology) ( Figure 3 ). Fourth, our approach for scoring articles inherently involves reviewer judgement to 284 determine author intent and to resolve ambiguities (e.g., determining whether the comparator is 285 "clearly" stated). We attempted to mitigate this problem by having two reviewers read each 286 article and, in cases where they could not reach agreement, appeal to a third reviewer.
287
Finally, our study's post-evaluation period may not be sufficiently long to detect the 288 impact of the reference case; as noted, the iDSI reference case was officially published in an 289 academic journal in 2016 (11). More time may be needed for the field to adopt these guidelines.
290
Policy implications 291 As posited by Nugent and Briggs, future research on the subject should ask, "what 292 specific help does the iDSI reference case offer the analyst, who, while attempting to conform to 293 the principles, nevertheless has to choose and implement the methods?" (22). It is possible that 294 the methodological guidelines impose an excessive burden on researchers, raising "issues about 295 the resources and data requirements to meet the principles" (16).
296
Future qualitative research should focus on researcher experience when conducting 297 global health-focused CEAs and on how to increase its acceptance among authors. Studies could 298 also evaluate the methods and reporting practices for articles that strongly adhere to the iDSI 299 reference case, as these analyses may serve as useful examples for other CEA authors attempting 300 to adhere to the guidelines. Future research should also evaluate the influence of the reference 301 case on how decision makers perceive the quality and usefulness of economic evaluations.
302
Moving from guideline development to implementation is a vital step towards improving 303 the utility of economic evaluations in global health. Future efforts could include additional 304 educational workshops for researchers, students, and policymakers. Policymakers and major 305 funders of economic evaluations, such as the BMGF, could require that researchers adhere to 306 reference case recommendations.
307
Conclusion
308
Our results indicate that the iDSI reference case has slightly improved reporting practices 309 of economic evaluations focused on global health, but not methodological practices. The 310 reference case has substantial potential to serve as a resource for researchers and policy makers 311 in global health and economics, but more effort to promote adherence and awareness may be 312 needed.
